Salve Technologies

Startup

Current gene therapies are mostly limited to plasmid-based and Adeno-associated virus variants with inefficient response rates and limited use.  Better viral delivery methods would expand the available gene therapy tool kit to produce precision medicines for intractable and incurable diseases. We are building VirCAD© (Virus Computer-Aided Design), an HPC-powered, cloud-accessible, AI/ML-capable bioCAD platform to mine, design, model and simulate new viral drugs for better cell and gene therapies, vaccines, oncolytics and antibiotics.  These modalities would be useful for treating and potentially curing the many inherited and acquired genetic disorders afflicting patients due to their therapeutic specificity, efficiency and irreversibility. 



Get involved with Advanced Therapies Congress

 

To speak


Jessica Robinson
Jessica.Robinson@terrapinn.com
+44 208 164 3086

 

 

To sponsor or exhibit


Ashlea Foster
Ashlea.Foster@terrapinn.com
+44 208 164 3032